COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 580: Articles 5791-5800  | Next

Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters
Rescigno, M., Agrati, C., Salvarani, C., Giannarelli, D., Costantini, M., Mantovani, A., Massafra, R., Zinzani, P. L., Morrone, A., Notari, S., Matusali, G., Lauria Pinter, G., Uccelli, A., Ciliberto, G., Baldanti, F., Locatelli, F., Silvestris, N., Sinno, V., Turola, E., VAX4FRAIL study Group, , Lupo Stanghellini, M. T., Apolone, G.
10.1101/2022.11.19.22282537 — Posted: 2022-11-19
Running ahead of evolution - AI based simulation for predicting future high-risk SARS-CoV-2 variants
Chen, J., Nie, Z., Wang, Y., Wang, K., Xu, F., Hu, Z., Zheng, B., Wang, Z., Song, G., Zhang, J., Fu, J., Huang, X., Wang, Z., Ren, Z., Wang, Q., Li, D., Wei, D., zhou, B., Yang, C., Tian, Y.
10.1101/2022.11.17.516989 — Posted: 2022-11-19
Factors associated with release relief of Long COVID symptoms at 12-Months and their impact on daily life
SALMON, D., SLAMA, D., LINARD, F., DUMESGES, N., LE BAUT, V., HAKIM, F., OUSTRIC, P., SEYRAT, E., THOREUX, P., MARSHALL, E.
10.1101/2022.11.18.22282459 — Posted: 2022-11-18
Long-term temporal trends in incidence rate and case fatality of sepsis and COVID-19-related sepsis: nationwide registry study
Skei, N. V., Nilsen, T. I., Knoop, S. T., Prescott, H., Lydersen, S., Mohus, R. M., Brkic, A., Liyanarachi, K. V., Solligaard, E., Damaas, J. K., Gustad, L. T.
10.1101/2022.11.18.22282501 — Posted: 2022-11-18
Special Olympics global report on COVID-19 vaccination and reasons not to vaccinate among adults with intellectual disabilities
Lincoln, A. E., Dixon-Ibarra, A. M., Hanley, J. P., Smith, A. L., Martin, K., Bazzano, A.
10.1101/2022.11.16.22282406 — Posted: 2022-11-18
Mindfulness supports emotional resilience in children during the COVID-19 Pandemic
Treves, I. N., Li, C., Wang, K., Ozernov-Palchik, O., Olson, H., Gabrieli, J.
10.1101/2022.11.18.22282510 — Posted: 2022-11-18
Comprative evaluation of Advanced Oxidation Processes (AOPs) for reducing SARS-CoV-2 viral load from campus sewage water
Pramanik, R., Bodawar, N., Brahme, A., Kamble, S., Dharne, M.
10.1101/2022.11.16.22282387 — Posted: 2022-11-18
Hospital length of stay throughout bed pathways and factors affecting this time: a non-concurrent cohort study of Colombia COVID-19 patients and an unCoVer network project
Ruiz Galvis, L. M., Perez Aguirre, C. A., Perez Bedoya, J. P., Mendoza Cardozo, O. I., Barengo, N. C., Sanchez Escudero, J. P., Cardona Jimenez, J., Diaz Valencia, P. A.
10.1101/2022.11.17.22282466 — Posted: 2022-11-18
Proteomic analysis of circulating immune cells identifies novel cellular phenotypes associated with COVID-19 severity
Potts, M., Fletcher-Etherington, A., Nightingale, K., Mescia, F., Bergamaschi, L., Calero-Nieto, F. J., Antrobus, R., Williamson, J., CITIID-NIHR COVID BioResource Collaboration, , Kingston, N., Gottgens, B., Bradley, J. R., Lehner, P. J., Matheson, N. J., Smith, K. G., Wills, M. R., Lyons, P. A., Weekes, M. P.
10.1101/2022.11.16.22282338 — Posted: 2022-11-18
Human Early Syncytiotrophoblasts Are Highly Susceptible to SARS-CoV-2 Infection
Liu, P., RUAN, D., Ye, Z.-W., Yuan, S., Li, Z., Zhang, W., Ong, C. P., Tang, K., Guo, J., Xuan, Y., Tam, T. T. K. K., Huang, Y., Zhang, Q., Lee, C.-L., Chiu, P. C. N., Liu, F., Jin, D.-Y.
10.1101/2022.11.17.516978 — Posted: 2022-11-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).